サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1184457

内視鏡的粘膜下層剥離術の世界市場：製品別 (把持器、クリップ、胃カメラ、結腸鏡)・適応症別 (がん (食道、胃、大腸))・エンドユーザー別 (病院、外来手術センター、専門クリニック) の将来予測 (2027年まで)

Endoscopic Submucosal Dissection Market by Product (Grasp, Clips, Gastroscopes, Colonoscopes), Indication (Cancer (Esophageal, Stomach, Colon), End User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics) - Global Forecast to 2027
出版日: | 発行: MarketsandMarkets | ページ情報: 英文 197 Pages | 納期: 即納可能 即納可能とは

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.76円
内視鏡的粘膜下層剥離術の世界市場：製品別 (把持器、クリップ、胃カメラ、結腸鏡)・適応症別 (がん (食道、胃、大腸))・エンドユーザー別 (病院、外来手術センター、専門クリニック) の将来予測 (2027年まで)
出版日: 2023年01月11日
発行: MarketsandMarkets
ページ情報: 英文 197 Pages
納期: 即納可能 即納可能とは
  • 全表示
  • 概要
  • 目次
概要

世界の内視鏡的粘膜下層剥離術 (ESD) の市場規模は、2022年の3億4,700万米ドルから、2027年には4億8,300万米ドルに達し、6.9%のCAGRで成長する、と予測されています。

市場の主な促進要因として、検出・治療処置における内視鏡の利用増加、がんの有病率の上昇、高齢者人口の増加などが挙げられます。一方、熟練した専門家の不足が、この市場の成長を抑制する主な要因となっています。

製品別に見ると、2021年には胃カメラ・結腸鏡のセグメントが最大のシェアを占めています。その主な要因として、エンドユーザーによる高い採用率、低侵襲処置に対する患者や医師の嗜好の高まり、内視鏡処置における継続的な技術進歩などが挙げられます。

適応症別では、2021年には胃がんセグメントが最大のシェアを占めています。その主な要因として、米国・中国・日本・インドにおける高齢者人口の増加、胃がんの発生率の上昇などが挙げられます。

エンドユーザー別に見ると、予測期間中は病院セグメントが最大のシェアを占めています。一人当たり所得の増加や、医療への関心増大などが挙げられます。

地域別に見ると、2021年には北米が世界市場を独占しました。その背景には、米国における内視鏡手術に対する有利な診療報酬政策、がんの有病率の増加、新しい機器の購入や新しい内視鏡手術の導入に向けた病院の多額の投資、内視鏡技術向上のための研究活動への強い注目、カナダの病院による新しい資金調達モデルの導入といった要因があります。

当レポートでは、世界の内視鏡的粘膜下層剥離術の市場について分析し、市場の基本構造や最新情勢、主な市場促進・抑制要因、製品別・適応症別・エンドユーザー別・地域別の市場動向の見通し、市場競争の状態、主要企業のプロファイルなどを調査しております。

目次

第1章 イントロダクション

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 重要考察

第5章 市場概要

  • イントロダクション
  • 市場力学
    • 促進要因
    • 抑制要因
    • 機会
    • 課題
  • 産業動向
    • 内視鏡的粘膜下層剥離術の牽引方法の進歩
    • ロボット支援内視鏡粘膜下解剖
  • 規制分析
  • エコシステム・市場マップ
  • バリューチェーン分析
  • ポーターのファイブフォース分析
  • 指標価格モデル分析
  • 特許分析
  • サプライチェーン分析
  • 主な会議とイベント (2022～2023年)
  • 主な利害関係者と購入基準

第6章 内視鏡的粘膜下層剥離術市場：製品別

  • イントロダクション
  • 胃カメラ・結腸鏡
  • ナイフ
  • 注射剤
  • 組織リトラクター
  • 把持器 (グラスパー)/クリップ
  • その他の製品

第7章 内視鏡的粘膜下層剥離術市場：適応症別

  • イントロダクション
  • 胃がん
  • 結腸がん
  • 食道がん

第8章 内視鏡的粘膜下層剥離術市場：エンドユーザー別

  • イントロダクション
  • 病院
  • 専門クリニック
  • 外来手術センター
  • その他のエンドユーザー

第9章 内視鏡的粘膜下層剥離術市場：地域別

  • イントロダクション
  • 北米
    • 米国
    • カナダ
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • 他の欧州諸国
  • アジア太平洋
    • 日本
    • 中国
    • インド
    • 他のアジア太平洋諸国
  • ラテンアメリカ
  • 中東・アフリカ

第10章 競合情勢

  • イントロダクション
  • 主要企業が採用した戦略
  • 主要企業の収益分析
  • 市場シェア分析
  • 企業フットプリントの分析
    • 企業フットプリント：製品別
    • 企業フットプリント：エンドユーザー別
    • 企業フットプリント：地域別
  • 企業評価マトリックス
  • 競合ベンチマーキング
  • 競合シナリオ
    • 製品の発売
    • 資本取引
    • その他の動向

第11章 企業プロファイル

  • 主要企業
    • OLYMPUS CORPORATION
    • FUJIFILM HOLDINGS CORPORATION
    • BOSTON SCIENTIFIC CORPORATION
    • MEDTRONIC
    • SUMITOMO BAKELITE CO., LTD.
    • CREO MEDICAL GROUP PLC
    • HOYA CORPORATION
    • CONMED CORPORATION
    • STERIS PLC
    • MTW ENDOSKOPIE MANUFAKTUR
  • その他の企業
    • OVESCO ENDOSCOPY AG
    • ZEON MEDICAL INC.
    • MICRO-TECH ENDOSCOPY
    • KARL STORZ SE & CO. KG
    • COOK MEDICAL
    • LEO MEDICAL CO., LTD.
    • ERBE ELEKTROMEDIZIN GMBH
    • TAEWOONG MEDICAL CO., LTD.
    • DCC HEALTHCARE LIMITED
    • KOSSEN CO., LTD.
    • INNOVAMEDICA S.P.A.
    • JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    • HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.
    • BEIJING ZKSK TECHNOLOGY CO., LTD.

第12章 付録

目次
Product Code: MD 8238

The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%.

Endoscopic submucosal dissection (ESD) is an advanced therapeutic endoscopy technique for superficial gastrointestinal neoplasms. In endoscopic submucosal dissection, the equipment includes different types of knives, forceps, snares, and a few other products that support the procedure, as well as accessories used to ease the handling of instruments during surgeries.

The global endoscopic submucosal dissection market is projected to reach USD 483 million by 2027 from USD 347 million in 2022, at a CAGR of 6.9%. Growth in this market is largely driven by the increasing use of endoscopy in detection and treatment procedures, the rising prevalence of cancer, and the growing geriatric population. On the other hand, the dearth of skilled professionals is a key factor restraining the growth of this market.

The gastroscopes and colonoscopes segment accounted for the largest share of the global endoscopic submucosal dissection market

In 2021, the gastroscopes and colonoscopes segment holds the largest share of the global endoscopic submucosal dissection market. The large share of this segment can be attributed to the higher adoption rate of this equipment by end users, the rising preference of patients and doctors for minimally invasive procedures, and ongoing technological advancements in endoscopy procedures.

The stomach cancer segment accounted for the largest share of the endoscopic submucosal dissection market in 2021

Based on indication, the endoscopic submucosal dissection market is segmented into esophageal cancer stomach cancer, colon cancer. The stomach cancer segment holds the largest share of the endoscopic submucosal dissection market in 2021. The large share of this segment can be attributed to the increasing geriatric population in the US, China, Japan, and India and the rising incidence of stomach cancer.

The hospitals' segment is expected to dominate the endoscopic submucosal dissection market during the forecast period

Based on end user, the endoscopic submucosal dissection market is segmented into ambulatory surgical centers, hospitals, specialty clinics, and other end users. The hospitals segment holds the largest share of the endoscopic submucosal dissection market during the forecast period owing to the the increasing per capita income and growing healthcare awareness.

North America dominated the endoscopic submucosal dissection market in 2021

North America dominated the endoscopic submucosal dissection market in 2021. The large share of North America in the global market is attributed to the favorable reimbursement policies for endoscopic procedures in the US, the increasing prevalence of cancer, high investments by hospitals to purchase new equipment and adopt new endoscopic procedures, strong focus on research activities to improve endoscopy techniques, as well as the implementation of a new funding model by Canadian hospitals.

The study contains insights from various industry experts, ranging from component suppliers to Tier 1 companies and OEMs. The break-up of the primaries is as follows:

  • By Company Type- Tier 1- 34%, Tier 2- 38% Tier 3 - 28%
  • By Designation- C level - 26%, Managers & Other Level - 74%
  • By Region- North America - 17%, Europe - 39%, Asia Pacific - 28%

Key players in the endoscopic submucosal dissection market

The prominent players in the endoscopic submucosal dissection market are Olympus Corporation (Japan), Boston Scientific Corporation (US), Sumitomo Bakelite Co., Ltd. (Japan), Creo Medical Group PLC (UK), Medtronic (Ireland), HOYA Corporation (Japan), ConMed Corporation (US), Steris Plc (Ireland), FUJIFILM Holdings Corporation (Japan), MTW Endoskopie Manufaktur (Germany), Ovesco Endoscopy AG (Germany), Zeon Medical Inc. (Japan), Micro-Tech Endoscopy (China), Karl Storz SE & CO. KG (Germany), Cook Medical (US), Leo Medical Co., Ltd. (China), Erbe Elektromedizin GmbH (Germany), Taewoong Medical Co., Ltd. (South Korea), DCC Healthcare Limited (Ireland), Kossen Co., Ltd. (South Korea), INNOVAMEDICA S.p.A. (Italy), Jiangsu Vedkang Medical Science and Technology Co., Ltd. (China), Hangzhou AGS Medical Technological Co., Ltd. (China), and Beijing ZKSK Technology Co., Ltd. (China).

Research Coverage:

The report analyzes the endoscopic submucosal dissection market and aims at estimating the market size and future growth potential of this market based on various segments such asproduct, indication, end user and region. The report also includes a product portfolio matrix of various endoscopic submucosal dissection products available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product offerings, and key market strategies.

Reasons to Buy the Report

The report will enrich established firms as well as new entrants/smaller firms to gauge the pulse of the market, which in turn would help them, garner a more significant share of the market. Firms purchasing the report could use one or any combination of the below-mentioned strategies to strengthen their position in the market.

This report provides insights into the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the global endoscopic submucosal dissection market. The report analyzes this market by product, indication, end user and region.
  • Product Enhancement/Innovation: Detailed insights on upcoming trends and product launches in the global endoscopic submucosal dissection market.
  • Market Development: Comprehensive information on the lucrative emerging markets byproduct, indication, end user and region.
  • Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global endoscopic submucosal dissection market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players in the global endoscopic submucosal dissection market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
    • 1.2.1 INCLUSIONS AND EXCLUSIONS
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • FIGURE 1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SEGMENTATION
  • 1.4 YEARS CONSIDERED
  • 1.5 CURRENCY CONSIDERED
    • TABLE 1 STANDARD CURRENCY CONVERSION RATES
  • 1.6 SCOPE-RELATED LIMITATIONS
  • 1.7 STAKEHOLDERS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 2 RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
    • 2.1.2 PRIMARY DATA
    • FIGURE 3 PRIMARY SOURCES
      • 2.1.2.1 Key data from primary sources
      • 2.1.2.2 Key industry insights
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 6 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION
  • 2.2 MARKET SIZE ESTIMATION
    • FIGURE 7 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS
    • FIGURE 8 REVENUE SHARE ANALYSIS ILLUSTRATION: OLYMPUS CORPORATION
    • FIGURE 9 SUPPLY-SIDE MARKET SIZE ESTIMATION: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET (2021)
    • FIGURE 10 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2022-2027)
    • FIGURE 11 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • FIGURE 12 TOP-DOWN APPROACH
  • 2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 13 DATA TRIANGULATION METHODOLOGY
  • 2.4 MARKET SHARE ESTIMATION
  • 2.5 STUDY ASSUMPTIONS
  • 2.6 METHODOLOGY-RELATED LIMITATIONS
  • 2.7 RISK ASSESSMENT
    • TABLE 2 RISK ASSESSMENT: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2022 VS. 2027 (USD MILLION)
    • FIGURE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2022 VS. 2027 (USD MILLION)
    • FIGURE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2022 VS. 2027 (USD MILLION)
    • FIGURE 17 GEOGRAPHIC SNAPSHOT OF ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET

4 PREMIUM INSIGHTS

  • 4.1 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET OVERVIEW
    • FIGURE 18 INCREASING USE OF ENDOSCOPY IN DETECTION AND TREATMENT PROCEDURES TO DRIVE MARKET GROWTH
  • 4.2 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT AND COUNTRY
    • FIGURE 19 GASTROSCOPES AND COLONOSCOPES HELD LARGEST SHARE OF ASIA PACIFIC MARKET IN 2021
  • 4.3 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC MIX
    • FIGURE 20 MARKET IN ASIA PACIFIC TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD
  • 4.4 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: REGIONAL MIX
    • FIGURE 21 NORTH AMERICA TO BE LARGEST MARKET FOR ENDOSCOPIC SUBMUCOSAL DISSECTION PRODUCTS THROUGHOUT FORECAST PERIOD
  • 4.5 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEVELOPED VS. DEVELOPING MARKETS
    • FIGURE 22 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH RATE DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing use of endoscopy in detection and treatment procedures
      • 5.2.1.2 Rising prevalence of cancer
    • FIGURE 24 GLOBAL CANCER INCIDENCE, 2008-2030
      • 5.2.1.3 Growing geriatric population
    • FIGURE 25 SHARE OF GERIATRIC POPULATION, BY REGION (2010-2030)
    • TABLE 3 GLOBAL CANCER INCIDENCE FOR GERIATRIC POPULATION (65-85+), 2020 VS. 2040
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Dearth of skilled professionals
      • 5.2.2.2 High overhead cost of ESD procedures with limited reimbursements
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Growing demand for minimally invasive procedures
      • 5.2.3.2 Growing investments in research and development of endoscopy technology
    • TABLE 4 MAJOR DEVELOPMENTS
      • 5.2.3.3 Expected increase in adoption of and preference for endoscopic submucosal dissection procedures in developing countries
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Higher rate of complications
      • 5.2.4.2 Risk of post-operative infection
  • 5.3 INDUSTRY TRENDS
    • 5.3.1 ADVANCES IN TRACTION METHODS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION
    • 5.3.2 ROBOT-ASSISTED ENDOSCOPIC SUBMUCOSAL DISSECTION
  • 5.4 REGULATORY ANALYSIS
    • 5.4.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 7 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • 5.4.2 NORTH AMERICA
      • 5.4.2.1 US
      • 5.4.2.2 Canada
    • 5.4.3 EUROPE
      • 5.4.3.1 Germany
      • 5.4.3.2 France
      • 5.4.3.3 UK
      • 5.4.3.4 Italy
  • 5.5 ECOSYSTEM MARKET MAP
    • FIGURE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: ECOSYSTEM MARKET MAP
  • 5.6 VALUE CHAIN ANALYSIS
    • FIGURE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: VALUE CHAIN ANALYSIS
  • 5.7 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.7.1 THREAT OF NEW ENTRANTS
      • 5.7.1.1 High capital requirement
      • 5.7.1.2 High preference for products from well-established brands
    • 5.7.2 THREAT OF SUBSTITUTES
      • 5.7.2.1 Presence of substitute therapies for endoscopic submucosal dissection
    • 5.7.3 BARGAINING POWER OF SUPPLIERS
      • 5.7.3.1 Presence of several raw material suppliers
      • 5.7.3.2 Supplier switching cost
    • 5.7.4 BARGAINING POWER OF BUYERS
      • 5.7.4.1 Limited number of companies offering premium products at global level
    • 5.7.5 INTENSITY OF COMPETITIVE RIVALRY
      • 5.7.5.1 Increasing demand for high-quality and innovative products
      • 5.7.5.2 Lucrative growth potential in emerging markets
  • 5.8 INDICATIVE PRICING MODEL ANALYSIS
    • TABLE 9 AVERAGE SELLING PRICE, BY PRODUCT (USD)
  • 5.9 PATENT ANALYSIS
    • 5.9.1 PATENT PUBLICATION TRENDS FOR ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
    • FIGURE 28 GLOBAL PATENT PUBLICATION TRENDS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015-2022
    • 5.9.2 TOP APPLICANTS (COMPANIES) FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS
    • FIGURE 29 TOP COMPANIES THAT APPLIED FOR PATENTS RELATED TO ENDOSCOPIC SUBMUCOSAL DISSECTION DEVICES AND MATERIALS, 2015-2022
    • 5.9.3 JURISDICTION ANALYSIS: TOP APPLICANTS (COUNTRIES) FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
    • FIGURE 30 JURISDICTION ANALYSIS: TOP APPLICANT COUNTRIES FOR PATENTS IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, 2015-2022
  • 5.10 SUPPLY CHAIN ANALYSIS
    • FIGURE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: STAKEHOLDERS IN SUPPLY CHAIN
  • 5.11 KEY CONFERENCES AND EVENTS DURING 2022-2023
    • TABLE 10 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS
  • 5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
    • 5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 32 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
    • TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP 3 APPLICATIONS
    • 5.12.2 BUYING CRITERIA
    • FIGURE 33 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS
    • TABLE 12 KEY BUYING CRITERIA FOR TOP 3 APPLICATIONS

6 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT

  • 6.1 INTRODUCTION
    • TABLE 13 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
  • 6.2 GASTROSCOPES AND COLONOSCOPES
    • 6.2.1 RISE IN COLON CANCER INCIDENCE TO DRIVE GROWTH
    • TABLE 14 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GASTROSCOPES AND COLONOSCOPES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.3 KNIVES
    • 6.3.1 IMPROVED EFFICACY, SAFETY, AND COST-EFFECTIVENESS OF KNIVES TO DRIVE MARKET GROWTH
    • TABLE 15 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR KNIVES, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.4 INJECTION AGENTS
    • 6.4.1 NEED FOR LOW-COST INJECTION AGENTS TO BOOST GROWTH
    • TABLE 16 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR INJECTION AGENTS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.5 TISSUE RETRACTORS
    • 6.5.1 RISING NUMBER OF SURGICAL PROCEDURES TO AID ADOPTION OF TISSUE RETRACTORS
    • TABLE 17 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR TISSUE RETRACTORS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.6 GRASPERS/CLIPS
    • 6.6.1 PATIENT SAFETY AND HIGH PRECISION OFFERED BY GRASPERS TO DRIVE THEIR DEMAND
    • TABLE 18 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR GRASPERS/CLIPS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 6.7 OTHER PRODUCTS
    • TABLE 19 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2020-2027 (USD MILLION)

7 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION

  • 7.1 INTRODUCTION
    • TABLE 20 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 21 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2021 (NUMBER OF PROCEDURES)
  • 7.2 STOMACH CANCER
    • 7.2.1 STOMACH CANCER OR GASTRIC CANCER ASSOCIATED WITH SIGNIFICANT PROPORTION OF ALL CANCER DEATHS
    • TABLE 22 ESTIMATED NUMBER OF NEW CASES OF STOMACH CANCER, BY REGION (2020-2040)
    • TABLE 23 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 24 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR STOMACH CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
  • 7.3 COLON CANCER
    • 7.3.1 COLON CANCER IS THIRD-MOST-COMMON CANCER AND SECOND-LEADING CAUSE OF CANCER DEATHS WORLDWIDE
    • TABLE 25 ESTIMATED NUMBER OF NEW CASES OF COLON CANCER, BY REGION (2020-2040)
    • TABLE 26 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 27 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR COLON CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)
  • 7.4 ESOPHAGEAL CANCER
    • 7.4.1 GROWING PREVALENCE OF ESOPHAGEAL CANCER ATTRIBUTED TO EXCESS TOBACCO AND ALCOHOL USE
    • TABLE 28 ESTIMATED NUMBER OF NEW CASES OF ESOPHAGEAL CANCER, BY REGION (2020-2040)
    • TABLE 29 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 30 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR ESOPHAGEAL CANCER, BY REGION, 2021 (NUMBER OF PROCEDURES)

8 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER

  • 8.1 INTRODUCTION
    • TABLE 31 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 8.2 HOSPITALS
    • 8.2.1 GROWING PREFERENCE FOR MINIMALLY INVASIVE SURGERIES AND ESD PROCEDURES TO SUPPORT GROWTH
    • TABLE 32 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR HOSPITALS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.3 SPECIALTY CLINICS
    • 8.3.1 TRANSITION FROM HOSPITAL-BASED PROCEDURES TO CLINIC-BASED PROCEDURES TO BOOST GROWTH
    • TABLE 33 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR SPECIALTY CLINICS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.4 AMBULATORY SURGICAL CENTERS
    • 8.4.1 GROWTH IN ASC SEGMENT DRIVEN BY INCREASING NUMBER OF OUTPATIENT VISITS
    • TABLE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR AMBULATORY SURGICAL CENTERS, BY COUNTRY, 2020-2027 (USD MILLION)
  • 8.5 OTHER END USERS
    • TABLE 35 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET FOR OTHER END USERS, BY COUNTRY, 2020-2027 (USD MILLION)

9 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION

  • 9.1 INTRODUCTION
    • FIGURE 34 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • TABLE 36 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY REGION, 2020-2027 (USD MILLION)
  • 9.2 NORTH AMERICA
    • FIGURE 35 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
    • TABLE 37 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 38 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 39 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 40 NORTH AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.2.1 US
      • 9.2.1.1 US is largest market for endoscopic submucosal dissection products
    • TABLE 41 US: MACROECONOMIC INDICATORS
    • TABLE 42 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 43 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 44 US: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.2.2 CANADA
      • 9.2.2.1 Slower healthcare development in Canada over past decade to restrain growth
    • TABLE 45 AGE-STANDARDIZED INCIDENCE RATES (ASIR) FOR SELECTED CANCERS IN MEN AND WOMEN IN CANADA, 2020 VS. 2040
    • TABLE 46 CANADA: MACROECONOMIC INDICATORS
    • TABLE 47 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 48 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 49 CANADA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.3 EUROPE
    • TABLE 50 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 51 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 52 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 53 EUROPE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.1 GERMANY
      • 9.3.1.1 Germany to account for largest share of European market
    • TABLE 54 GERMANY: MACROECONOMIC INDICATORS
    • TABLE 55 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 56 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 57 GERMANY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.2 FRANCE
      • 9.3.2.1 High-quality healthcare system offering coverage to all citizens to support market growth
    • TABLE 58 FRANCE: MACROECONOMIC INDICATORS
    • TABLE 59 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 60 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 61 FRANCE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.3 UK
      • 9.3.3.1 Investments by hospitals to purchase new and advanced endoscopic submucosal dissection equipment to propel market
    • TABLE 62 UK: MACROECONOMIC INDICATORS
    • TABLE 63 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 64 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 65 UK: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.4 ITALY
      • 9.3.4.1 Receptivity of government toward high-quality and technologically advanced equipment to foster growth
    • TABLE 66 ITALY: MACROECONOMIC INDICATORS
    • TABLE 67 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 68 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 69 ITALY: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.5 SPAIN
      • 9.3.5.1 Rising prevalence of cancer to drive market growth
    • TABLE 70 SPAIN: MACROECONOMIC INDICATORS
    • TABLE 71 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 72 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 73 SPAIN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.3.6 REST OF EUROPE
    • TABLE 74 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 75 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 76 ROE: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.4 ASIA PACIFIC
    • FIGURE 36 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SNAPSHOT
    • TABLE 77 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY COUNTRY, 2020-2027 (USD MILLION)
    • TABLE 78 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 79 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 80 ASIA PACIFIC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.1 JAPAN
      • 9.4.1.1 Supportive medical device reimbursement policies to drive market growth
    • TABLE 81 JAPAN: MACROECONOMIC INDICATORS
    • TABLE 82 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 83 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 84 JAPAN: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.2 CHINA
      • 9.4.2.1 Large patient population and strong need for healthcare infrastructure improvements to boost market growth
    • TABLE 85 CHINA: MACROECONOMIC INDICATORS
    • TABLE 86 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 87 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 88 CHINA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.3 INDIA
      • 9.4.3.1 Favorable government initiatives for healthcare infrastructure improvements to support market growth
    • TABLE 89 INDIA: MACROECONOMIC INDICATORS
    • TABLE 90 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 91 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 92 INDIA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
    • 9.4.4 REST OF ASIA PACIFIC
    • TABLE 93 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 94 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 95 ROAPAC: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.5 LATIN AMERICA
    • 9.5.1 INCREASING PURCHASING POWER AND HEALTHCARE AFFORDABILITY WILL FAVOR MARKET GROWTH
    • TABLE 96 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 97 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 98 LATIN AMERICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)
  • 9.6 MIDDLE EAST AND AFRICA
    • 9.6.1 HEALTHCARE INFRASTRUCTURAL ADVANCEMENTS WILL CREATE NEED FOR HOSPITAL EQUIPMENT AND MEDICAL DEVICES
    • TABLE 99 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY PRODUCT, 2020-2027 (USD MILLION)
    • TABLE 100 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY INDICATION, 2020-2027 (USD MILLION)
    • TABLE 101 MIDDLE EAST & AFRICA: ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET, BY END USER, 2020-2027 (USD MILLION)

10 COMPETITIVE LANDSCAPE

  • 10.1 INTRODUCTION
  • 10.2 STRATEGIES ADOPTED BY KEY PLAYERS
  • 10.3 REVENUE ANALYSIS OF KEY MARKET PLAYERS
    • FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS OPERATING IN ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET
  • 10.4 MARKET SHARE ANALYSIS
    • FIGURE 38 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET SHARE, BY KEY PLAYER (2021)
  • 10.5 COMPANY FOOTPRINT ANALYSIS
    • 10.5.1 FOOTPRINT OF COMPANIES, BY PRODUCT
    • 10.5.2 FOOTPRINT OF COMPANIES, BY END USER
    • 10.5.3 FOOTPRINT OF COMPANIES, BY REGION
  • 10.6 COMPANY EVALUATION MATRIX
    • 10.6.1 STARS
    • 10.6.2 EMERGING LEADERS
    • 10.6.3 PERVASIVE PLAYERS
    • 10.6.4 PARTICIPANTS
    • FIGURE 39 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: COMPANY EVALUATION MATRIX
  • 10.7 COMPETITIVE BENCHMARKING
    • TABLE 102 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: KEY START-UPS/SMES
  • 10.8 COMPETITIVE SCENARIO
    • 10.8.1 PRODUCT LAUNCHES
    • TABLE 103 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: PRODUCT LAUNCHES (JANUARY 2019-DECEMBER 2022)
    • 10.8.2 DEALS
    • TABLE 104 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: DEALS (JANUARY 2019-DECEMBER 2022)
    • 10.8.3 OTHER DEVELOPMENTS
    • TABLE 105 ENDOSCOPIC SUBMUCOSAL DISSECTION MARKET: OTHER DEVELOPMENTS (JANUARY 2019-DECEMBER 2022)

11 COMPANY PROFILES

  • (Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)**
  • 11.1 KEY PLAYERS
    • 11.1.1 OLYMPUS CORPORATION
    • TABLE 106 OLYMPUS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 40 COMPANY SNAPSHOT: OLYMPUS CORPORATION (2022)
    • 11.1.2 FUJIFILM HOLDINGS CORPORATION
    • TABLE 107 FUJIFILM HOLDINGS CORPORATION: BUSINESS OVERVIEW
    • FIGURE 41 COMPANY SNAPSHOT: FUJIFILM HOLDINGS CORPORATION (2021)
    • 11.1.3 BOSTON SCIENTIFIC CORPORATION
    • TABLE 108 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW
    • FIGURE 42 COMPANY SNAPSHOT: BOSTON SCIENTIFIC CORPORATION (2021)
    • 11.1.4 MEDTRONIC
    • TABLE 109 MEDTRONIC: BUSINESS OVERVIEW
    • FIGURE 43 COMPANY SNAPSHOT: MEDTRONIC (2022)
    • 11.1.5 SUMITOMO BAKELITE CO., LTD.
    • TABLE 110 SUMITOMO BAKELITE CO., LTD.: BUSINESS OVERVIEW
    • FIGURE 44 COMPANY SNAPSHOT: SUMITOMO BAKELITE CO., LTD. (2021)
    • 11.1.6 CREO MEDICAL GROUP PLC
    • TABLE 111 CREO MEDICAL GROUP PLC: BUSINESS OVERVIEW
    • FIGURE 45 COMPANY SNAPSHOT: CREO MEDICAL GROUP PLC (2021)
    • 11.1.7 HOYA CORPORATION
    • TABLE 112 HOYA CORPORATION: BUSINESS OVERVIEW
    • FIGURE 46 COMPANY SNAPSHOT: HOYA CORPORATION (2022)
    • 11.1.8 CONMED CORPORATION
    • TABLE 113 CONMED CORPORATION: BUSINESS OVERVIEW
    • FIGURE 47 COMPANY SNAPSHOT: CONMED CORPORATION (2021)
    • 11.1.9 STERIS PLC
    • TABLE 114 STERIS PLC: BUSINESS OVERVIEW
    • FIGURE 48 COMPANY SNAPSHOT: STERIS PLC (2022)
    • 11.1.10 MTW ENDOSKOPIE MANUFAKTUR
    • TABLE 115 MTW ENDOSKOPIE MANUFAKTUR: BUSINESS OVERVIEW
  • 11.2 OTHER PLAYERS
    • 11.2.1 OVESCO ENDOSCOPY AG
    • TABLE 116 OVESCO ENDOSCOPY AG: BUSINESS OVERVIEW
    • 11.2.2 ZEON MEDICAL INC.
    • TABLE 117 ZEON MEDICAL INC.: BUSINESS OVERVIEW
    • 11.2.3 MICRO-TECH ENDOSCOPY
    • TABLE 118 MICRO-TECH ENDOSCOPY: BUSINESS OVERVIEW
    • 11.2.4 KARL STORZ SE & CO. KG
    • TABLE 119 KARL STORZ SE & CO. KG.: BUSINESS OVERVIEW
    • 11.2.5 COOK MEDICAL
    • TABLE 120 COOK MEDICAL: BUSINESS OVERVIEW
    • 11.2.6 LEO MEDICAL CO., LTD.
    • TABLE 121 LEO MEDICAL CO., LTD.: BUSINESS OVERVIEW
    • 11.2.7 ERBE ELEKTROMEDIZIN GMBH
    • TABLE 122 ERBE ELEKTROMEDIZIN GMBH: BUSINESS OVERVIEW
    • 11.2.8 TAEWOONG MEDICAL CO., LTD.
    • TABLE 123 TAEWOONG MEDICAL CO., LTD.: BUSINESS OVERVIEW
    • 11.2.9 DCC HEALTHCARE LIMITED
    • TABLE 124 DCC HEALTHCARE LIMITED: BUSINESS OVERVIEW
    • 11.2.10 KOSSEN CO., LTD.
    • TABLE 125 KOSSEN CO., LTD.: BUSINESS OVERVIEW
    • 11.2.11 INNOVAMEDICA S.P.A.
    • TABLE 126 INNOVAMEDICA S.P.A.: BUSINESS OVERVIEW
    • 11.2.12 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.
    • TABLE 127 JIANGSU VEDKANG MEDICAL SCIENCE AND TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
    • 11.2.13 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.
    • TABLE 128 HANGZHOU AGS MEDICAL TECHNOLOGICAL CO., LTD.: BUSINESS OVERVIEW
    • 11.2.14 BEIJING ZKSK TECHNOLOGY CO., LTD.
    • TABLE 129 BEIJING ZKSK TECHNOLOGY CO., LTD.: BUSINESS OVERVIEW
  • *Details on Business Overview, Products/Solutions/Services Offered, Recent Developments, MnM view (Key strengths/Right to win, Strategic choices made, Weakness/competitive threats)** might not be captured in case of unlisted companies.

12 APPENDIX

  • 12.1 DISCUSSION GUIDE
  • 12.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 12.3 CUSTOMIZATION OPTIONS
  • 12.4 RELATED REPORTS
  • 12.5 AUTHOR DETAILS